Safety and benefit of incretin-based therapies in patients with type 2 diabetes: learnings and reflections. Issue 3 (4th March 2022)

Record Type:: Journal Article
Title:: Safety and benefit of incretin-based therapies in patients with type 2 diabetes: learnings and reflections. Issue 3 (4th March 2022)
Main Title:: Safety and benefit of incretin-based therapies in patients with type 2 diabetes: learnings and reflections
Authors:: Rizvi, Ali A.
Linhart, Ales
Vrablik, Michal
Liberopoulos, Evangelos
Rizzo, Manfredi
Abstract:
Is Part Of:: Expert opinion on drug safety. Volume 21:Issue 3(2022)
Journal:: Expert opinion on drug safety
Issue:: Volume 21:Issue 3(2022)
Issue Display:: Volume 21, Issue 3 (2022)
Year:: 2022
Volume:: 21
Issue:: 3
Issue Sort Value:: 2022-0021-0003-0000
Page Start:: 291
Page End:: 293
Publication Date:: 2022-03-04
Subjects:: Drugs -- Side effects -- Periodicals
Drugs -- Toxicology -- Periodicals
Chemotherapy -- Periodicals
615.704
Journal URLs:: http://informahealthcare.com/journal/eds ↗
http://informahealthcare.com ↗
http://ninetta.ashley-pub.com/vl=3523218/cl=72/nw=1/rpsv/journal/journal3_home.htm ↗
DOI:: 10.1080/14740338.2022.2043848 ↗
Languages:: English
ISSNs:: 1474-0338
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3842.002945
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 21003.xml